Gaelle Mercenne is now head of biology for Seattle’s Talus Bioscience. The startup last month announced $11.2 million in new funding to advance its drug discovery program for hard-to-treat diseases.

Learn More Talus, the next-gen platform for onchain AI agents, is joining forces with Sui, the blockchain that wants to enable mass adoption of Web3. Talus enables developers to launch tokenized ...